Latest News

Novo Nordisk investors get a second bite at the Ozempic apple.

Crypto investors have, by one measure, never been this panicked before.

Most Americans admit to wasting money. But it's not what most people blame. Here's where it actually goes.

Both stocks are down right now, but both have strengths for the long term.

These tech leaders pay small but growing dividends that could add up over many years.

Ditching cash changes more than how you think about spending. It changes how you split bills, handle emergencies, get paid back, and even how you travel.

Diversification is overlooked by many investors, but it can be a powerful tool for building long-term wealth.

This forgotten stock might be too risky even for contrarian investors.

High-yield savings accounts offer rates as competitive as top CDs right now -- with no lock-up period. Here's why flexibility wins in today's rate environment.

Pet food company Freshpet (NASDAQ:FRPT) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.6% year on year to $285.2 million. Its GAAP profit of $0.64 per share was 64.7% above analysts’ consensus estimates.

There's a leveraged ETF that could magnify SoFi's returns in your portfolio.

Novo's next-gen drug CagriSema didn't match weight loss from Eli Lilly's Zepbound.

Stanley Druckenmiller added a small position in Wolfspeed in Q4.

Fast-food pizza chain Domino’s (NYSE:DPZ) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 6.4% year on year to $1.54 billion. Its GAAP profit of $5.35 per share was 0.7% below analysts’ consensus estimates.

The market didn't appreciate AMD's latest quarterly results.

These businesses are strong, and the stocks seem to be on sale.

Nio shares climbed in premarket trading Monday, bucking a broader market pullback, as the company's battery-swap network notched multiple single-day records during the 2026 Spring Festival period.